Anti-CYP8B1 antibody

• WB

Supplier Data

Western blot - Anti-CYP8B1 antibody (AB191910)

All lanes:

Western blot - Anti-CYP8B1 antibody (ab191910)

Lane 1:

HEK293T whole cell lysate

Lane 2:

RAW 264.7 whole cell lysate

Lane 3:

H9C2 whole cell lysate

Predicted band size: 58 kDa

false

• WB

CiteAb

Western blot - Anti-CYP8B1 antibody (AB191910)

CYP8B1 western blot using anti-CYP8B1 antibody ab191910. Publication image and figure legend from Chen, G. & Wu, S., 2020, Gastroenterol Res Pract, PubMed 32382260.

ab191910 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab191910 please see the product overview.

Lithogenic diet induced disorders of cholesterol synthesis and transport in liver. (a–c) The mRNA levels of cholesterol 7α-hydroxylase (CYP7a1) (a), sterol 12α-hydroxylase (CYP8b1) (b), and liver X receptor α (LXRα) (c) in the liver were detected by real-time PCR. (d) Western blot was used to measure the protein levels of CYP7a1, CYP8b1, adenosine triphosphate binding cassette (ABC)G5, ABCG8, and LXRα in the liver of mice that received a lithogenic diet or Baicalin administration. (e–i) Quantitative analysis of CYP7a1 (e), CYP8b1 (f), ABCG5 (g), ABCG8 (h), and LXRα (i) of immunoblot bands in (d). (j) Immunohistochemistry staining was used for detection of LXRα expression in the liver (the scale bar represented 50 μm). n = 6 (*p < 0.05, **p < 0.01, and ***p < 0.001). ns : no significance; BA(L) : 50 mg/kg baicalin; BA(H) : 100 mg/kg baicalin.

false